Moderna Shares Fall Nearly 18% as Vaccine Rally Falters
Moderna shares plunged nearly 18% to close at $202.63 on Thursday. Mizuho analyst Jared Holz called the stock a “do-not-trade” for many investors because of extreme volatility.
Moderna’s (MRNA) cancer-vaccine rally hit a setback on Thursday as shares slid toward their worst week in three months and Mizuho analyst Jared Holz warned that extreme volatility made the stock a “do-not-trade” for many investors.MRNA stock plunged nearly 18% to close at $202.63 on Thursday, its w…